Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome-A propensity score matched analysis.

ABSTRACT:

SUBMITTER: Americo AD 

PROVIDER: S-EPMC11726069 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature